{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:26:25Z","timestamp":1790796385189,"version":"4.1.0"},"reference-count":74,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01763","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T04:15:00Z","timestamp":1513224900000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":64,"title":["Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis"],"prefix":"10.3389","volume":"8","author":[{"given":"Manas Ranjan","family":"Dikhit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budheswar","family":"Dehury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaya Kumar","family":"Rout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fauzia","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh Chandra","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan Kamal","family":"Topno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. N. R.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiva","family":"Bimal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,12,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e313","DOI":"10.1371\/journal.pntd.0000313","article-title":"Complexities of assessing the disease burden attributable to leishmaniasis","volume":"2","author":"Bern","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"B2","volume-title":"Neglected Tropical Diseases, Hidden Successes, Emerging Opportunities","year":"2009"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.1016\/j.vaccine.2006.05.008","article-title":"The antipoverty vaccines","volume":"24","author":"Hotez","year":"2006","journal-title":"Vaccine"},{"key":"B4","volume-title":"The Bottom Billion: Why the Poorest Countries Are Failing and What Can Be Done about it","author":"Collier","year":"2007"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12879-017-2192-4","article-title":"A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure","volume":"17","author":"Eichenberger","year":"2017","journal-title":"BMC Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","article-title":"Leishmaniasis and poverty","volume":"22","author":"Alvar","year":"2006","journal-title":"Trends Parasitol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.molimm.2016.12.022","article-title":"Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb\/c mice","volume":"82","author":"Amit","year":"2017","journal-title":"Mol Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.0105-2896.2004.00190.x","article-title":"Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?","volume":"201","author":"McMahon-Pratt","year":"2004","journal-title":"Immunol Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","article-title":"CD4 T cells: fates, functions, and faults","volume":"112","author":"Zhu","year":"2008","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1128\/IAI.73.6.3823-3827.2005","article-title":"CD4+ T cells play a dominant role in protection against New World leishmaniasis induced by vaccination with the P-4 amastigote antigen","volume":"73","author":"Kar","year":"2005","journal-title":"Infect Immun"},{"key":"B14","first-page":"53","article-title":"Interleukin-10 and transforming growth factor-\u03b2 in early and late lesions of patients with Leishmania major induced cutaneous leishmaniasis","volume":"7","author":"Hejazi","year":"2012","journal-title":"Iran J Parasitol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2180-14-8","article-title":"IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccine","volume":"14","author":"Bhowmick","year":"2014","journal-title":"BMC Microbiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e3091","DOI":"10.1371\/journal.pntd.0003091","article-title":"Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection","volume":"8","author":"Das","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1672-0229(08)60037-6","article-title":"Computational analysis of cysteine proteases (Clan CA, family C1) of Leishmania major to find potential epitopic regions","volume":"7","author":"Saffari","year":"2009","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1089\/hum.1998.9.13-1899","article-title":"Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis","volume":"9","author":"Walker","year":"1998","journal-title":"Hum Gene Ther"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4+ T cells","volume":"75","author":"Coler","year":"2007","journal-title":"Infect Immun"},{"key":"B20","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1128\/IAI.62.11.4893-4899.1994","article-title":"The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation","volume":"62","author":"Tolson","year":"1994","journal-title":"Infect Immun"},{"key":"B21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijpara.2014.08.013","article-title":"Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis","volume":"45","author":"Yadav","year":"2015","journal-title":"Int J Parasitol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.vaccine.2011.11.005","article-title":"The development and clinical evaluation of second-generation leishmaniasis vaccines","volume":"30","author":"Duthie","year":"2012","journal-title":"Vaccine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1016\/j.vaccine.2005.07.001","article-title":"Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals","volume":"23","author":"Gradoni","year":"2005","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.trstmh.2005.04.002","article-title":"Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia","volume":"99","author":"V\u00e9lez","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1590\/S0074-02762002000700019","article-title":"Study of the safety, immunogenicity and efficacy of attenuated and killed Leishmania (Leishmania) major vaccines in a rhesus monkey (Macaca mulatta) model of the human disease","volume":"97","author":"Amaral","year":"2002","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0966-842X(97)01180-3","article-title":"Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania","volume":"6","author":"Beverley","year":"1998","journal-title":"Trends Microbiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/j.1469-0691.2011.03610.x","article-title":"Visceral leishmaniasis: immunology and prospects for a vaccine","volume":"17","author":"Kaye","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"B28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fmicb.2016.00467","article-title":"Post-genomics and vaccine improvement for Leishmania","volume":"7","author":"Seyed","year":"2016","journal-title":"Front Microbiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.vaccine.2005.01.059","article-title":"Developing an epitope-driven tuberculosis (TB) vaccine","volume":"23","author":"De Groot","year":"2005","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fimmu.2014.00268","article-title":"Experimental validation of multi-epitope peptides including promising MHC class I-and II-restricted epitopes of four known Leishmania infantum proteins","volume":"5","author":"Agallou","year":"2014","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/jcb.26190","article-title":"Mining the proteome of Leishmania donovani for the development of novel MHC class I restricted epitope for the control of visceral leishmaniasis","volume":"119","author":"Dikhit","year":"2018","journal-title":"J Cell Biochem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-1-60327-118-9_5","article-title":"SYFPEITHI: database for searching and T-cell epitope prediction","volume":"409","author":"Schuler","year":"2007","journal-title":"Methods Mol Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/1471-2105-11-568","article-title":"Peptide binding predictions for HLA DR, DP and DQ molecules","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/1471-2105-10-296","article-title":"NN-align","volume":"10","author":"Nielsen","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1093\/nar\/26.17.3986","article-title":"Protein sequence similarity searches using patterns as seeds","volume":"26","author":"Zhang","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"609289","DOI":"10.1155\/2013\/609289","article-title":"Computational elucidation of structural basis for ligand binding with Leishmania donovani adenosine kinase","volume":"2013","author":"Kar","year":"2013","journal-title":"Biomed Res Int"},{"key":"B37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13073-016-0288-x","article-title":"NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets","volume":"8","author":"Nielsen","year":"2016","journal-title":"Genome Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e12451","DOI":"10.1111\/pim.12451","article-title":"Vaccine potential of HLA A2 epitopes from Leishmania cysteine protease type III (CPC)","volume":"39","author":"Dikhit","year":"2017","journal-title":"Parasite Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"W498","DOI":"10.1093\/nar\/gkp323","article-title":"PEP-FOLD: an online resource for de novo peptide structure prediction","volume":"37","author":"Maupetit","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"W363","DOI":"10.1093\/nar\/gki481","article-title":"PatchDock and SymmDock: servers for rigid and symmetric docking","volume":"33","author":"Schneidman-Duhovny","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1006\/viro.1999.9859","article-title":"Prediction of three-dimensional structure and mapping of conformational epitopes of envelope glycoprotein of Japanese encephalitis virus","volume":"261","author":"Kolaskar","year":"1999","journal-title":"Virology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1046\/j.1365-2567.1996.d01-673.x","article-title":"Immunogenicity of peptides for B cells is not impaired by overlapping T-cell epitope topology","volume":"88","author":"Harris","year":"1996","journal-title":"Immunology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol Direct"},{"key":"B44","doi-asserted-by":"publisher","first-page":"42851","DOI":"10.1038\/srep42851","article-title":"Computer-aided designing of immunosuppressive peptides based on IL-10 inducing potential","volume":"7","author":"Nagpal","year":"2017","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jmgm.2016.11.012","article-title":"Structural dynamics of casein kinase I (CKI) from malarial parasite Plasmodium falciparum (Isolate 3D7): insights from theoretical modelling and molecular simulations","volume":"71","author":"Dehury","year":"2017","journal-title":"J Mol Graph Model"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1128\/MCB.00344-16","article-title":"Phosphorylation of translation initiation factor 2-alpha in Leishmania donovani under stress is necessary for parasite survival","volume":"37","author":"Abhishek","year":"2017","journal-title":"Mol Cell Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"6697","DOI":"10.1128\/IAI.70.12.6697-6706.2002","article-title":"Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB\/c mice","volume":"70","author":"Afrin","year":"2002","journal-title":"Infect Immun"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2016.1263240","article-title":"Identification of B-cell epitope of Leishmania donovani and its application in diagnosis of visceral leishmaniasis","author":"Jamal","year":"2016","journal-title":"J Biomol Struct Dyn"},{"key":"B49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-4939-7015-5_6","article-title":"Predicting secretory proteins with signalP","volume":"1611","author":"Nielsen","year":"2017","journal-title":"Methods Mol Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.meegid.2016.08.037","article-title":"Computational prediction and analysis of potential antigenic CTL epitopes in Zika virus: a first step towards vaccine development","volume":"45","author":"Dikhit","year":"2016","journal-title":"Infect Genet Evol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.meegid.2015.10.012","article-title":"Computational elucidation of potential antigenic CTL epitopes in Ebola virus","volume":"36","author":"Dikhit","year":"2015","journal-title":"Infect Genet Evol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.micinf.2017.03.002","article-title":"Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects","volume":"19","author":"Amit","year":"2017","journal-title":"Microbes Infect"},{"key":"B53","doi-asserted-by":"publisher","first-page":"6620","DOI":"10.1128\/IAI.73.10.6620-6628.2005","article-title":"Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells","volume":"73","author":"Bertholet","year":"2005","journal-title":"Infect Immun"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/infdis\/jiu531","article-title":"Interleukin 17A acts synergistically with interferon \u03b3 to promote protection against Leishmania infantum infection","volume":"211","author":"Nascimento","year":"2014","journal-title":"J Infect Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e943","DOI":"10.1371\/journal.pntd.0000943","article-title":"Vaccines for the leishmaniases: proposals for a research agenda","volume":"5","author":"Costa","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1365-2249.2005.02768.x","article-title":"Dichotomy of protective cellular immune responses to human visceral leishmaniasis","volume":"140","author":"Khalil","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/pmic.200800533","article-title":"Mining the Leishmania genome for novel antigens and vaccine candidates","volume":"9","author":"Herrera-Najera","year":"2009","journal-title":"Proteomics"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.4161\/hv.21881","article-title":"Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines","volume":"8","author":"Elfaki","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"B59","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1128\/IAI.66.7.3100-3105.1998","article-title":"Leishmania pifanoi amastigote antigen P-4: epitopes involved in T-cell responsiveness in human cutaneous leishmaniasis","volume":"66","author":"Haberer","year":"1998","journal-title":"Infect Immun"},{"key":"B60","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1517\/14712598.4.6.767","article-title":"Immunome-derived vaccines","volume":"4","author":"De Groot","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"B61","first-page":"273","article-title":"Immunogenicity of HLA-DR1 restricted peptides derived from Leishmania major gp63 using FVB\/N-DR1 transgenic mouse model","volume":"8","author":"Rezvan","year":"2013","journal-title":"Iran J Parasitol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.meegid.2017.05.022","article-title":"Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach","volume":"53","author":"Kashyap","year":"2017","journal-title":"Infect Genet Evol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fimmu.2016.00327","article-title":"Combination of in silico methods in the search for potential CD4+ and CD8+ T cell epitopes in the proteome of Leishmania braziliensis","volume":"7","author":"Silva","year":"2016","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1745-7580-3-5","article-title":"Strength in numbers: achieving greater accuracy in MHC-I binding prediction by combining the results from multiple prediction tools","volume":"3","author":"Trost","year":"2007","journal-title":"Immunome Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.leukres.2006.02.010","article-title":"Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A* 0201 molecules","volume":"30","author":"Gomez-Nunez","year":"2006","journal-title":"Leuk Res"},{"key":"B66","first-page":"1","article-title":"12th International Histocompatibility Conference. Genetic diversity of HLA: functional and medical implications","volume":"47","author":"Garrido","year":"1996","journal-title":"Hum Immunol"},{"key":"B67","first-page":"21","article-title":"A model of phenotypic susceptibility to tuberculosis: deficient in silico selection of Mycobacterium tuberculosis epitopes by HLA alleles","volume":"25","author":"Contini","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e108556","DOI":"10.1371\/journal.pone.0108556","article-title":"Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis","volume":"9","author":"Jaiswal","year":"2014","journal-title":"PLoS One"},{"key":"B69","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.cyto.2017.01.001","article-title":"Adenosine generated by ectonucleotidases modulates the host immune system during visceral leishmaniasis","volume":"91","author":"Amit","year":"2017","journal-title":"Cytokine"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e0154117","DOI":"10.1371\/journal.pone.0154117","article-title":"Elevated serum ADA activity as a marker for diagnosis and prognosis of visceral leishmaniasis and post kala-azar dermal leishmaniasis in indian patients","volume":"11","author":"Amit","year":"2016","journal-title":"PLoS One"},{"key":"B71","doi-asserted-by":"publisher","first-page":"ra121","DOI":"10.1126\/scitranslmed.3006406","article-title":"Vaccination with Leishmania hemoglobin receptor\u2013encoding DNA protects against visceral leishmaniasis","volume":"5","author":"Guha","year":"2013","journal-title":"Sci Transl Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cellimm.2016.07.004","article-title":"Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines","volume":"309","author":"Banerjee","year":"2016","journal-title":"Cell Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1172\/JCI38813","article-title":"IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani","volume":"119","author":"Pitta","year":"2009","journal-title":"J Clin Invest"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.vaccine.2003.06.002","article-title":"Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis","volume":"22","author":"Armijos","year":"2004","journal-title":"Vaccine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01763\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T08:05:02Z","timestamp":1603526702000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01763\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,14]]},"references-count":74,"alternative-id":["10.3389\/fimmu.2017.01763"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01763","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,14]]},"article-number":"1763"}}